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Aim To identify genetic variants underlying biochemical 
traits – total cholesterol, low-density lipoprotein (LDL) cho-
lesterol, high-density lipoprotein (HDL) cholesterol, triglyc-
erides, uric acid, albumin, and fibrinogen, in a genome-
wide association study in an isolated population where 
rare variants of larger effect may be more easily identified.
Methods The study included 944 adult inhabitants of the 
island of Korčula, as a part of larger DNA-based genetic ep-
idemiological study in 2007. Biochemical measurements 
were performed in a single laboratory with stringent in-
ternal and external quality control procedures. Examinees 
were genotyped using Human Hap370CNV chip by Illu-
mina, with a genome-wide scan containing 346 027 single 
nucleotide polymorphisms (SNP).
Results A total of 31 SNPs were associated with 7 inves-
tigated traits at the level of P < 1.00 × 10−5. Nine of SNPs 
implicated the role of SLC2A9 in uric acid regulation 
(P = 4.10 × 10−6-2.58 × 10−12), as previously found in oth-
er populations. All 22 remaining associations fell into the 
P = 1.00 × 10−5-1.00 × 10−6 significance range.. One of them 
replicated the association between cholesteryl ester trans-
fer protein (CETP) and HDL, and 7 associations were more 
than 100 kilobases away from the closest known gene. 
Nearby SNPs, rs4767631 and rs10444502, in gene kinase 
suppressor of ras 2 (KSR2) on chromosome 12 were asso-
ciated with LDL cholesterol levels, and rs10444502 in the 
same gene with total cholesterol levels. Similarly,  rs2839619 
in gene PBX/knotted 1 homeobox 1 (PKNOX1) on chromo-
some 21 was associated with total and LDL cholesterol 
levels. The remaining 9 findings implied possible associa-
tions between phosphatidylethanolamine N-methyltrans-
ferase (PEMT) gene and total cholesterol; USP46, RAP1GDS1, 
and ZCCHC16 genes and triglycerides; BCAT1 and SLC14A2 
genes and albumin; and NR3C2, GRIK2, and PCSK2 genes 
and fibrinogen.
Conclusion Although this study was underpowered for 
most of the reported associations to reach formal thresh-
old of genome-wide significance under the assumption 
of independent multiple testing, replications of previous 
findings and consistency of association between the iden-
tified variants and more than one studied trait make such 
findings interesting for further functional follow-up stud-
ies. Changed allele frequencies in isolate population may 
contribute to identifying variants that would not be easily 
identified in much larger samples in outbred populations.
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It is known that human lipid levels in circulation show 
considerable heritability (1-3). Recently, genome-wide as-
sociation studies proved their value as a reliable tool for 
identifying genetic variants underlying complex human 
diseases and traits (4,5). The first applications of genome-
wide association studies to identify genetic variants un-
derlying human lipid levels yielded a total of 19 loci con-
trolling serum high-density lipoprotein cholesterol (HDL), 
low-density lipoprotein cholesterol (LDL), and triglycerides 
(6-10) and implicated a number of potential genes and 3 
genetic regions with multiple associated genes. Many of 
these genes have already been known as very likely can-
didates for lipid level regulation (11,12). The most recent 
study also found that ATP-binding cassette gene (ABCG5) 
predicted triglycerides and LDL; transmembrane protein 
57 gene (TMEM57) predicted triglycerides; regulator pro-
tein with 11 highly conserved zinc finger-protein arginine 
methyltransferase 8 regions (CTCF-PRMT8 region) predict-
ed HDL; dynein, axonemal, heavy chain 11 (DNAH11) pre-
dicted LDL; fatty acid desaturase 3 – fatty acid desaturase 2 
gene (FADS3-FADS2) predicted triglycerides and LDL; and 
MAP-kinase activating death domain-folate hydrolase 1 
gene (MADD-FOLH1 region) predicted HDL (13). However, 
all these loci combined can still not explain a substantial 
share of noted heritabilities, leaving room for further find-
ings of genetic and epigenetic factors that control serum 
lipid levels in humans (14). Those are likely to include struc-
tural variants, such as copy number variants, and also very 
rare genetic variants that may only be identified in special 
populations (4,5).
Apart from the lipid levels, other clinically relevant bio-
chemical measurements in human serum and/or plasma 
that are usually studied include uric acid, albumin, and fi-
brinogen. Recently, several studies have identified and rep-
licated the finding of a novel major uric acid transporter 
– solute carrier family 2 (facilitated glucose transporter) 
member 9 – SLC2A9 (GLUT9), which is several times more 
functionally significant than urate transporter 1 – URAT1, 
a gene previously thought to play a major role in the reg-
ulation of uric acid levels (15-18). A recent study with in-
creased power has identified further 2 genes that also 
contribute to uric acid regulation: ATP-binding cassette, 
sub-family G (WHITE) member 2 – ABCG2 and solute car-
rier family 17 member 3 – SLC17A3 (19). Unlike for uric acid, 
we could not find any genome-wide association studies 
that searched specifically for loci influencing the levels of 
human albumin in plasma. Some genome-wide associa-
tion studies investigating biochemical traits also included 
searching for fibrinogen loci, but none of them reached 
the required threshold for genome-wide significance (20).
We performed a comprehensive genome-wide associa-
tion studies of total cholesterol, LDL and HDL cholester-
ol, triglycerides, uric acid, albumin, and fibrinogen in the 
isolated population of the island of Korčula in Croatia. The 
study is a part of genetic epidemiology research program 
in Croatian island isolates, “10,001 Dalmatians.” The genet-
ic epidemiology research program in Croatian island iso-
lates began in 1999 (21), expanded to study human ge-
netic variation and effects of isolation and inbreeding 
(22-34), and then broadened its focus to include diseases 
and gene mapping studies (18,35-41). By now, the research 
project has included more than 3000 examinees from iso-
lated populations, while it aims to eventually reach 10 001 
examinees.
MATeRIALS AnD MeTHoDS
This study was performed in the eastern part of the island 
of Korčula, Croatia between March and December 2007. 
Healthy volunteers aged 18 and over from the town of 
Korčula and villages Lumbarda, Žrnovo, and Račišće (Fig-
ure 1) were invited to the study through mail, posters, ra-
dio, and personal contacts.
The study was approved by the Ethical Committee of the 
Medical School, University of Zagreb, and all examinees 
had signed an informed consent. There was a total of 969 
examinees included who had a number of quantitative 
phenotypic traits measured.
Biochemical analyses of 7 traits were performed on blood 
samples taken from the examinees after overnight fast-
ing (collected between 8:30 and 9:30 am). We collected 
9 mL clotted serum-gel sample for serum biochemis-
try, 2 × 10mL EDTA samples for DNA extraction or liquid 
nitrogen storage of aliquots for future transformation, 
Figure 1.
Settlements on the island of Korčula, Croatia, included in the study.
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TABLe 1. A summary of single-nucleotide polymorphisms (SNP) that showed association with biochemical traits that 
reached levels of genome-wide significance of P < 10−5*†
SnP for trait Chromosome Position
effect
allele
effect allele
frequency
Korčula
effect allele
frequency
HapMap P value β
Standard
error (β) Gene
Total cholesterol
rs7678182  4 32117038 A 0.428 0.367 9.9 × 10−06   0.119 0.027 no genes +/− 200kb
rs1493762 12 90604046 C 0.158 0,180 7.6 × 10−06 -0.224 0.050 no genes +/− 200kb
rs10777332 12 90688433 A 0,113 0.161 5.1 × 10−06 -0.235 0.051 no genes +/− 200kb
rs10444502 12 116838254 C 0.279 0,267 6.1 × 10−06 -0.165 0.036 kinase supressor of ras 2 (KSR2)
rs8081810 17 17463669 G 0.1692 0.083 9.8 × 10−06   0.222 0.050
phosphatidylethanolamine N-methyl-
transferase (PEMT )
rs2839619 21 43309246 G 0.396 0.525 7.6 × 10−06   0.127 0.028 PBX/knotted 1 homeobox 1 (PKNOX1)
LDL cholesterol
rs4767631 12 116796126 A 0.313 0.333 5.5 × 10−07 -0.167 0.033 kinase supressor of ras 2 (KSR2)
rs10444502 12 116838254 C 0.280 0.267 6.4 × 10−07 -0.182 0.036 kinase supressor of ras 2 (KSR2)
rs2839619 21 43309246 G 0.395 0.525 8.0 × 10−06   0.127 0.028 PBX/knotted 1 homeobox 1 (PKNOX1)
HDL cholesterol
rs4599440  4 61648868 A 0.233 0.275 1.6 × 10−06   0.199 0.041 Latrophilin-3 precursor (LPHN3) on 100kb
rs871392 12 40458249 A 0.152 0,133 3.0 × 10−06 -0.255 0.054 no genes +/− 200kb
rs7499892 16 55564091 A 0.164 0.175 9.0 × 10−06 -0.235 0.053
cholesteryl ester transfer protein, plasma 
(CETP)
Triglycerides
rs346923  4 53106886 A 0.132 0.075 1.6 × 10−06   0.276 0.057 ubiquitin specific protease 46 (USP46)
rs10516430  4 99556904 A 0.283 0.283 5.9 × 10−06 -0.163 0.036
RAP1, GTP-GDP dissociation stimulator 1 
(RAP1GDS1)
rs5982533  X 111533120 G 0.221 0.167 6.6 × 10−06 -0.227 0.050
zinc finger CCHC domain containing 16 
(ZCCHC16)
Uric acid  
rs10805346  4 9529445 G 0.409 0.492 8.4 × 10−09 -0.162 0.028 solute carrier family 2, member 9 (SLC2A9)
rs13129697  4 9536065 C 0.249 0.350 2.5 × 10−12 -0.287 0.041 solute carrier family 2, member 9 (SLC2A9)
rs737267  4 9543842 A 0.203 0.308 6.1 × 10−09 -0.273 0.046 solute carrier family 2, member 9 (SLC2A9)
rs4505821  4 9587192 A 0.207 0.175 4.1 × 10−06   0.215 0.046 solute carrier family 2, member 9 (SLC2A9)
rs13131257  4 9590987 A 0.173 0.225 8.0 × 10−09 -0.300 0.052 solute carrier family 2, member 9 (SLC2A9)
rs6449213  4 9603313 G 0.163 0.242 1.2 × 10−09 -0.330 0.054 solute carrier family 2, member 9 (SLC2A9)
rs1014290  4 9610959 G 0.205 0.308 7.5 × 10−12 -0.320 0.046 solute carrier family 2, member 9 (SLC2A9)
rs733175  4 9659239 G 0.162 0.242 1.8 × 10−06 -0.252 0.052 solute carrier family 2, member 9 (SLC2A9)
rs6820756  4 9671947 A 0.191 0.725 1.4 × 10−06 -0.229 0.047 solute carrier family 2, member 9 (SLC2A9)
Albumin
rs10505955 12 24985488 G 0.477 0.467 9.5 × 10−06   0.104 0.023
branched chain aminotransferase 1 cyto-
solic (BCAT1)
rs10502868 18 41407947 G 0.075 0.092 6.5 × 10−06 -0.359 0.079
solute carrier family 14, member 2 
(SLC14A2)
Fibrinogen
rs1490453  4 149540796 A 0.170 0.208 3.1 × 10−06   0.249 0.053
nuclear receptor subfamily 3, group C, 
member 2 (NR3C2)
rs12207601  6 102462560 G 0.161 0.136 2.4 × 10−06 -0.257 0.054 glutamate receptor 6 (GRIK2)
rs6044777 20 17316542 A 0.174 0.183 7.9 × 10−06   0.227 0.050
proprotein convertase subtilisin/kexin 
type 2 (PCSK2)
rs1840485  X 6229033 A 0.239 0.208 3.2 × 10−06 -0.231 0.049 X-linked neuroligin 4 on 73kb
rs7885458  X 6230474 G 0.238 0.208 2.9 × 10−06 -0.233 0.049 X-linked neuroligin 4 on 74kb
*Abbreviations: LDL – low-density lipoprotein; HDL – high-density lipoprotein.
†The table summarizes SnPs, their positions on the chromosomes, P values, effect size and direction (expressed as β and standard error of β), effect allele, and implicated gene; 
the information on each gene was obtained from ref. 46.
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and a 10 mL citrate sample for clotting factor analysis 
(S-Monovette, Sarstedt, Leicester, UK). Plasma and se-
rum were rapidly frozen and stored at -80°C in 500 μL al-
iquots using standardized sample handling procedures. 
They were then transported frozen, within a maximum 
of 3 days, to a single biochemical laboratory (Salzer, Za-
greb, Croatia). The laboratory was chosen as it was inter-
nationally accredited for performing this type of analy-
sis and included in internal quality assessment by Roche 
and Olympus, as well as in external monitoring programs 
by Croatian reference center for biochemical measure-
ments and RIQAS international agency for quality con-
trol (42). Methods of biochemical analyses performed 
to measure the levels of total cholesterol, LDL and HDL 
cholesterol, triglycerides, uric acid, albumin, and fibrino-
gen followed standard internationally agreed procedures 
and they were described in detail in previous articles (43). 
DNA extraction was performed using Nucleon kits (Tep-
nel, Manchester, UK), and 944 were genotyped at the GSF 
Research Center for Environment and Health in Munich, 
Germany. Genotyping was performed using Illumina Hu-
manHap 370CNV (Illumina, San Diego, CA, USA), with a 
total of 346 027 SNP markers. Quality control of the gen-
otype data, excluding markers with a call rate <98%, or 
minor allele frequency <2%, or out of Hardy-Weinberg 
equilibrium (P < 1E-10) left 316 730 SNPs in the analysis. 
Removal of individuals with a call rate of <97% left 898 
people for inclusion in the analysis. Genome-wide asso-
ciations between anthropometric phenotypes (adjusted 
for age and sex) and SNP markers were analyzed by the 
“mmscore” function of the GenABEL R statistical package 
(44), using an additive model. This score test for family 
based association accounts for pedigree structure and al-
lows unbiased estimations of SNP allelic effect (45). No 
correction for multiple testing was applied. The relation-
ship matrix used in this analysis was generated by the 
“identity-by-state” function of GenABEL which used iden-
tity-by-state (ibs) genotype sharing to determine the re-
alized pair-wise kinship coefficient similarly to the PLINK 
genome function. All identified SNPs that reached signif-
icance or seemed to be suggestive were visualized us-
ing Haploview software, which was also used for calcu-
lation of linkage disequilibrium measures. The methods 
of genotyping and statistical genetic analyses necessary 
to perform a GWAS of a quantitative biological trait in an 
isolate population where familial relationships need to 
be taken into account were described in great detail in 
our previous publications (18). Pearson correlation coef-
ficient was used in the correlation analysis performed 
in SPSS, version 13 (SPSS Inc, Chicago, IL, USA).
ReSULTS
A total of 31 SNPs were associated with the investigated 
traits at the level of P < 1.0 × 10−5 (Table 1). SNP rs10444502 
in kinase suppressor of ras 2 gene (KSR2) located on chro-
mosome 12 was associated with total cholesterol levels 
(P = 6.1 × 10−6), while two nearby SNPs on the chromosome 
12 (rs1493762 and rs10777332), each of them slightly more 
than 100 kilobases from KSR2, showed similar level of sig-
nificance of association (Table 1, Figure 2). These two SNPs 
were in complete linkage disequilibrium (r2 = 1, D’ = 1). This 
finding is particularly interesting because two other SNPs 
(rs4767631 and rs10444502) in the same gene (KSR2), lo-
cated close to each other on chromosome 12, were as-
sociated with LDL cholesterol levels (Table 1, Figure 3). 
rs4767631 and rs10444502 are in weak linkage disequilib-
rium (r2 = 0.426, D’ = 0.766).
Similarly, the SNP rs2839619 in PBX/knotted 1 homeobox 
1 gene (PKNOX1) on chromosome 21 was associated with 
both total and LDL cholesterol levels. This makes KSR2 and 
PKNOX1 interesting candidates for further replication and 
follow-up functional studies. The remaining possible asso-
ciations between genetic variants and the levels of total 
cholesterol were phosphatidylethanolamine N-methyl-
transferase gene (PEMT; P = 9.9 × 10−6) and rs7678182 on 
chromosome 4 with no known genes in proximity less 
than 100 kilobases (P = 9.9 × 10−6).
Genetic variants influencing HDL levels are shown in Fig-
ure 4. Two loci at chromosomes 4 and 12 showed high 
level of significance of association, but no known genes 
were present within 100 kilobases of the two loci. How-
ever, the third finding (rs7499892 on chromosome 16; 
P = 9.9 × 10−6) replicated an already reported association 
between cholesteryl ester transfer protein gene (CETP) 
and HDL, confirming the role of CETP gene in the regula-
tion of plasma HDL levels. The correlation coefficient be-
tween LDL and HDL was 0.46 (P < 0.001), LDL and total cho-
lesterol 0.53 (P < 0.001), and HDL and total cholesterol 0.83 
(P < 0.001).
We found 3 variants influencing triglyceride levels in 
Korčula island population at the level P < 1.0 × 10−5 (Table 
1, Figure 5): SNP rs346923 on chromosome 4 found within 
ubiquitin specific protease 46 gene (USP46, P = 1.6 × 10−6); 
SNP rs10516430 on chromosome 4 within RAP1, GTP-GDP 
dissociation stimulator 1 gene (RAP1GDS1, P = 5.9 × 10−6); 
and SNP rs5982533 on chromosome X, within zinc finger 
CCHC domain 16 (ZCCHC16, P = 6.6 × 10−6).
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Figure 2.
Results of genome-wide association study of total serum cholesterol levels (mmol/L) using Haploview software, showing peaks at chromosomes 4, 12, 17, 
and 21 reaching genome-wide significance level of P < 10−5.
Figure 3.
Results of genome-wide association study of serum low-density lipoprotein cholesterol levels (mmol/L) using Haploview software, showing peaks at 
chromosomes 12 and 21 reaching genome-wide significance level of P < 10−5.
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Figure 4.
Results of genome-wide association study of serum high-density lipoprotein cholesterol levels (mmol/L) using Haploview software, showing peaks at 
chromosomes 4, 12, and 16 reaching genome-wide significance level of P < 10−5.
Figure 5.
Results of genome-wide association study of serum triglyceride levels (mmol/L) using Haploview software, showing peaks at chromosomes 4 and X 
reaching genome-wide significance level of P < 10−5.
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Table 1 shows that nearly one-third of 31 SNP association 
findings from this study implicated the role of SLC2A9 in 
uric acid regulation. Significance of this association ranged 
between P = 4.1 × 10−6 and 2.58 × 10−12. The highly signifi-
cant peak at chromosome 4, shown in Figure 6, represents 
a convincing replication of previous findings in other pop-
ulations. Linkage disequilibrium pattern of SNPs associated 
with uric acid regulation for the CEU population (popula-
tion of western European ancestry) is shown in Figure 7.
Genome-wide association study of albumin and fibrin-
ogen conducted at Korčula island represents one of the 
first attempts to obtain insights into genetic regulation of 
those two traits. The most significant findings were pos-
sible roles of branched chain aminotransferase 1 cytosolic 
gene (BCAT1) and solute carrier family 14 member 2 gene 
(SLC14A2) in the regulation of albumin levels (Table 1, Fig-
ure 8). Fibrinogen yielded 5 results at the level P < 1.0 × 10−5 
(Table 1, Figure 9). Two of them, located close to each other 
on chromosome X, were not found within or near to any 
known genes. Other results highlighted the possible role of 
the genes nuclear receptor subfamily 3 group C member 2 
(NR3C2) on chromosome 4, glutamate receptor 6 (GRIK2) 
on chromosome 6, and proprotein convertase subtilisin/
kexin type 2 (PCSK2) on chromosome 20.
DISCUSSIon
Our study of nearly 1000 examinees focused on 7 stand-
ard biochemical measurements and revealed a total of 31 
SNPs associated with the investigated traits at the level of 
P < 1.00 × 10−5. Nine of those SNPs (nearly one third) impli-
Figure 6.
Results of genome-wide association study of uric acid levels (µmol/L) using Haploview software, showing a single, highly significant peak at chromosome 
4 reaching genome-wide significance level of P < 10−5.
Figure 7.
P linkage disequilibrium pattern of short nucleotide polymorphisms 
(SnP) associated with uric acid regulation for the CeU population (of 
western european ancestry) calculated using Haploview software, show-
ing r2 values.
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Figure 8.
Results of genome-wide association study of serum albumin levels (g/L) using Haploview software, showing peaks at chromosomes 12 and 18 reaching 
genome-wide significance level of P < 10−5.
Figure 9.
Results of genome-wide association study of fibrinogen levels (g/L) using Haploview software, showing peaks at chromosomes 4, 6, 20, and X reaching 
genome-wide significance level of P < 10−5.
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cated the role of SLC2A9 in uric acid regulation, which is a 
replication of previous findings in other populations. The re-
maining 20 associations fell into statistical significance range 
P = 1.00 × 10−5-1.00 × 10−6. One of them replicated the associ-
ation between CETP and HDL (47,48). Recent 3 GWASs iden-
tified nearly 20 new loci affecting total cholesterol, LDL cho-
lesterol, HDL cholesterol, and triglycerides (18,49,50). All 3 
studies confirmed the association between CETP gene and 
HDL cholesterol. However, loci identified in these 3 studies 
are different than 15 loci for serum lipid levels reported in 
our study. The replications of SLC2A9 and CETP findings add 
to reliability of other findings reported in this study and of 
genome-wide association approach in general.
Two nearby SNPs in KSR2 gene on chromosome 12 were 
associated with LDL cholesterol levels and another SNP in 
KSR2 gene with total cholesterol levels. This is an intrigu-
ing finding, because very little is known about the func-
tion of this gene in humans, but mice in which this gene 
has been knocked out show a striking phenotype of ex-
treme obesity (51). Similarly, the SNP rs2839619 in PKNOX1 
gene on chromosome 21 was associated with both total 
and LDL cholesterol levels. This is another intriguing find-
ing, because the role of this gene in cancer development 
has long been hypothesized without ever gathering much 
strong evidence, but the most recent study found that the 
deficiency of PKNOX1 gene induced protection from di-
abetes and increased insulin sensitivity through a p160-
mediated mechanism (52). In addition, the third gene im-
plicated in cholesterol regulation, PEMT, is a liver-specific 
enzyme that converts phosphatidylethanolamine to phos-
phatidylcholine (53). It has been shown recently that mice 
that lack PEMT gene have reduced plasma levels of phos-
phatidylcholine and cholesterol in HDL (53). This makes all 
3 genes – KSR2, PKNOX1, and PEMT – interesting candidate 
genes for the regulation of cholesterol levels. Further rep-
lication and functional studies will be needed to reaffirm 
their role in cholesterol regulation in humans.
Among the other findings, 7 associations were more than 
100 kilobases away from the closest known gene and their 
true importance is yet to be replicated and explained. The 
remaining 8 findings implied possible associations be-
tween the three genes (deubiquitinating enzyme gene 
– USP46; exchange factor SMG P21 stimulatory GDP/GTP 
exchange protein gene – RAP1GDS1; and zinc finger CCHC 
domain 16 – ZCCHC16) and triglycerides; the two genes 
(branched-chain-amino-acid aminotransferase, cytosolic 
gene – BCAT1; and solute carrier family 14 (urea transport-
er) member 2 gene - SLC14A2) and albumin; and the three 
genes (nuclear receptor subfamily 3 group C member 2 
gene – NR3C2; glutamate receptor, ionotropic, kainate 2 
gene – GRIK2; and proprotein convertase subtilisin/kexin 
type 2 gene - PCSK2) and fibrinogen. No information is cur-
rently available on the roles and functions of these genes 
that would help understand their possible role in regulat-
ing levels of human biochemical traits. BCAT1 gene has 
been identified through genome-wide association studies 
as a gene that confers the risk of diabetes type 2 in several 
populations (54), while SLC14A2 is only known as a pre-
dicted urea transporter (55).
The results presented here suggest that some identified 
genes were implicated in more than one trait, suggesting 
that they might be responsible for the genetic action on 
the common underlying property for these traits. Others, 
such as PEMT gene, represent promising and biologically 
plausible functional candidates. The shortcomings of this 
study primarily include the potential low statistical power, 
which is a consequence of the limited population size en-
countered in any genetic isolate. The target for this study 
was to sample approximately 1000 examinees, which could 
be supplemented with more in the future, in order to in-
crease the statistical power of the study. Additionally, the 
studies performed in isolated populations should always 
seek replication to ensure that the findings are indeed rep-
resentative of wider general human populations and not 
limited to specific circumstances of a particular isolate. Fi-
nally, variants identified in this study all require functional 
follow-up and replication in other populations in order to 
establish their true significance in determination of human 
biochemical traits.
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